Healthcare Industry Forecast’s Post

Drug Discovery Services Market Worth $41.3 billion by 2028 🔵𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐑𝐄𝐄 𝐒𝐚𝐦𝐩𝐥𝐞:https://lnkd.in/diXdYs_N The global drug discovery services market in terms of revenue was estimated to be worth $20.6 billion in 2023 and is poised to reach $41.3 billion by 2028, growing at a CAGR of 14.9% from 2023 to 2028. 🔵 𝐌𝐚𝐢𝐧 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬: X-Chem, Inc. Quantori NanoCellect Biomedical, Inc.      FUJIFILM Cellular Dynamics, Inc    Iambic Therapeutics  Sygnature Discovery XtalPi Inc. Skyhawk Therapeutics    BPS Bioscience Inc.     Biocytogen  Anima Biotech   The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology Active Motif Reaction Biology Kallyope NETZSCH Premier Technologies, LLC       o2h discovery      Structure Therapeutics     Terray Therapeutics Remix Therapeutics       Eureka Therapeutics, Inc    Neomorph, Inc.      Charnwood Discovery   ACEA Biosciences  Plexium   AnaSpec Eurofins DiscoverX HTG Molecular Diagnostics       Calibr-Skaggs Institute for Innovative Medicines        MBL International Corporation     GemPharmatech Belharra Therapeutics HotSpot Therapeutics, Inc.   Neuron23       Jubilant Biosys Limited        Cajal Neuroscience NanoImaging Services  Skills Alliance abcam BenevolentAI 

Have you seen the agenda for the inaugural Biophysics for Drug Discovery Summit? View the full event guide here: https://lnkd.in/euNY6aWy This summit is an essential drug discovery initiative where biophysicists and drug discovery experts converge to unlock the hidden potential of biophysical techniques, revolutionizing the creation of next-gen therapeutics Here's what awaits you:   🚀 Dive deep into cutting-edge strategies like DNA-encoded libraries and fragment-based screening with industry giants Pfizer, GSK, and Eli Lilly and Company to supercharge your hit identification and validation processes   🔍 Gain exclusive insights from top experts tackling complex biological challenges at Amgen, Biogen, and Expansion Therapeutics—setting the stage for your research and ensuring triumph in drug discovery   🌐 Expand your network with key players in biophysics and drug discovery from Sanofi, Merck Group, Accent Therapeutics, Inc. , Novo Nordisk, Kestrel Therapeutics, and many more Access your full program and registration options here: https://lnkd.in/euNY6aWy 2024 Event Partners include: WuXi AppTec | NanoTemper Technologies Any questions, please don't hesitate to reach out Olivia Grace Edwards Arthur Marriott Luke Kindness Rona Perry #biophysics #drugdiscovery #drugdevelopment #biophysical

Will the Global Cell Therapy Technologies Market Reach $7.8 Billion by 2028 with a CAGR of 13.3%? 𝐔𝐧𝐥𝐨𝐜𝐤 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 | 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞: https://lnkd.in/dnyXKdhb The global cell therapy technologies market, valued at approximately $4.2 billion in 2023, is poised to expand to $7.8 billion by 2028, achieving a compound annual growth rate (CAGR) of 13.3% during the forecast period. Key players shaping this market include Thermo Fisher Scientific, Merck KGaA, Darmstadt, Germany, Danaher Corporation, BD, Lonza, and Sartorius. These companies drive innovation in cell therapy technology, contributing to advancements in regenerative medicine and biotechnology. Factors driving market growth include increasing investment in biotechnology research, rising prevalence of chronic diseases, and advancements in cell-based therapies worldwide. #CellTherapy #RegenerativeMedicine #Biotechnology #HealthcareInnovation #MedicalResearch #GlobalHealth #Biotech #StemCells #CancerTreatment #CellularTherapy #ThermoFisherScientific #MerckKGaA #DanaherCorporation #BD #LonzaGroup #SartoriusAG #MarketResearch #HealthcareTrends #HealthcareIndustry #MarketForecast #HealthTech #MedicalEquipment #Biopharma #DrugDevelopment #HealthcareInvestment #MedicalTechnology #GlobalMarket #MarketGrowth #HealthcareServices #HealthcareProviders #DigitalHealth #PrecisionMedicine #PersonalizedMedicine #HealthcareCosts #HealthcareAccessibility #HealthcareEcosystem #EmergingMarkets #PublicHealth #HealthcarePolicy #HealthcareQuality #HealthcareManagement #HealthcareStartups #HealthcareProfessionals #HealthcareStrategy #HealthcareChallenges #HealthcareSustainability #HealthcareLeadership #HealthcareEducation #HealthcareAwareness #HealthcareImpact #HealthcareDisruption #HealthcareFuture #HealthcareEquality #HealthcareEquity #HealthcareWorkforce #GlobalHealthcare #HealthcareCollaboration #HealthcarePartnerships #HealthcareAdvancements #HealthcareGoals #HealthcareVision #MedicalTraining #MedicalResearch #Bioengineering #BiomedicalResearch #BiomedicalEngineering #CellTherapyTechnologies #TherapeuticCells #TissueEngineering #LifeSciences #Bioprocessing #CellCulture #GeneTherapy #Immunotherapy #CellBasedTherapy #DrugDiscovery #ClinicalTrials #HealthcareSystems #DigitalTransformation #BiotechIndustry #HealthcareTech

Oligonucleotide Synthesis Market Worth $19.7 Billion Download a PDF Brochure: https://lnkd.in/dQqqzbjq Oligonucleotide Synthesis Market by Product (Drugs (ASO, siRNA), Synthesized Oligo (Primer), Reagents, Equipment), Type (Custom, Predesigned), Application (Therapeutic (Neurology, Rare), Research (PCR, Sequencing), Diagnostics) - Global Forecast to 2029 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞: Danaher Corporation, Thermo Fisher Scientific, Merck KGaA, Darmstadt, Germany, Eurofins, LGC, Agilent Technologies, Kaneka Corporation (Japan), Maravai Lifesciences holdings, Inc. (US), Azenta, Inc. (US), Twist Bioscience Corporation (US) and Genscript Biotech Corporation (US). Major players in the oligonucleotide therapeutics market are Biogen Inc. (US), Alnylam Pharmaceuticals, Inc. (US), Sarepta Therapeutics, Inc. (US), Astrazeneca (UK), Astellas Pharma Inc. (Japan), Jazz Pharmaceuticals Plc (Ireland), Nippon Shinyaku, Co. Ltd. (Japan), Ionis Pharmaceuticals, Inc. (US) and Novartis AG (Switzerland) Other Companies that are Operating in this Market Globally: Genesis Therapeutics QuartzBio, part of Precision for Medicine Cytovance Biologics XBiotech USA, Inc. Elektrofi Envisagenics C2N Diagnostics Arbutus Biopharma Corporation Focused Ultrasound Foundation Remix Therapeutics Immunome, Inc. VGXI BioTissue Ocular Adimab IPA (ImmunoPrecise Antibodies)    Flare Therapeutics Inhibrx Biosciences, Inc. ALX Oncology XOMA Royalty Precigen Kezar Life Sciences BioAtla, Inc. Equillium, Inc. Acumen Pharmaceuticals, Inc. Tilda Research Sonata Therapeutics  MERIT CRO Next Science Target RWE BioMap Asahi Kasei Bioprocess America, Inc.  Nutcracker Therapeutics BioNTech SE HARBOUR BIOMED #OligonucleotideSynthesis #Genomics #DNASequencing #MolecularBiology #GeneticResearch #Biotechnology #GeneEditing #SyntheticBiology #NucleicAcids #OligoSynthesis #DNAAmplification #RNAResearch #GeneticEngineering #BiotechInnovation #MolecularDiagnostics #GeneticTesting #LaboratoryTech #BioResearch #Nucleotides #SynthesisTechnology

From $𝟒.𝟐 𝐁𝐢𝐥𝐥𝐢𝐨𝐧 𝐭𝐨 $𝟕.𝟖 𝐁𝐢𝐥𝐥𝐢𝐨𝐧: Rapid Expansion of the 𝐂𝐞𝐥𝐥 𝐓𝐡𝐞𝐫𝐚𝐩𝐲 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐢𝐞𝐬 Market through 𝟐𝟎𝟐𝟖 𝐔𝐧𝐥𝐨𝐜𝐤 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 | 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞: https://lnkd.in/dnyXKdhb The global cell therapy technologies market was valued at approximately $4.2 billion in 2023 and is projected to grow to $7.8 billion by 2028, achieving a compound annual growth rate (CAGR) of 13.3% during this period. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞: Thermo Fisher Scientific (US), Merck KGaA, Darmstadt, Germany (Germany), Danaher Corporation (US), BD (US), 𝐋𝐨𝐧𝐳𝐚 𝐆𝐫𝐨𝐮𝐩 (Switzerland), Sartorius AG (Germany). 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐨𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐬𝐞𝐜𝐭𝐨𝐫 𝐠𝐥𝐨𝐛𝐚𝐥𝐥𝐲 𝐚𝐫𝐞: Gamida Cell Ltd. Kite Pharma  AGC Biologics BlueRock Therapeutics Poseida Therapeutics, Inc. Iovance Biotherapeutics, Inc. FUJIFILM Irvine Scientific  Arsenal Biosciences, Inc. Lyell Immunopharma Center for Breakthrough Medicines GenScript ProBio CARGO Therapeutics Sorrento Therapeutics, Inc. Arcellx Parse Biosciences Vericel® Corporation Sonoma Biotherapeutics Carisma Therapeutics A2 Biotherapeutics, Inc. Cognate BioServices, a Charles River Company Nkarta, Inc. Capricor Therapeutics, Inc. Affini-T Therapeutics Adicet Bio, Inc Artiva Biotherapeutics FUJIFILM Cellular Dynamics, Inc Shoreline Biosciences, Inc. Cellipont Bioservices PBS Biotech Paragon Bioservices, Inc. Neurona Therapeutics    Genezen BioCentriq PeproTech Adaptimmune 𝐂𝐓𝐌𝐂 / 𝐀 𝐣𝐨𝐢𝐧𝐭 𝐯𝐞𝐧𝐭𝐮𝐫𝐞 𝐛𝐞𝐭𝐰𝐞𝐞𝐧 𝐑𝐞𝐬𝐢𝐥𝐢𝐞𝐧𝐜𝐞 + 𝐌𝐃 𝐀𝐧𝐝𝐞𝐫𝐬𝐨𝐧 𝐂𝐚𝐧𝐜𝐞𝐫 𝐂𝐞𝐧𝐭𝐞𝐫    𝐏𝐫𝐨𝐊𝐢𝐝𝐧𝐞𝐲 𝐂𝐨𝐫𝐩.    𝐂𝐂𝐑𝐌    𝐓𝐞𝐬𝐬𝐚 𝐓𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜𝐬 𝐋𝐭𝐝    𝐛𝐢𝐭.𝐛𝐢𝐨    𝐐𝐮𝐞𝐥𝐥 𝐓𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜𝐬    𝐎𝐮𝐭𝐩𝐚𝐜𝐞 𝐁𝐢𝐨    𝐑𝐄𝐆𝐑𝐎𝐖 𝐁𝐈𝐎𝐒𝐂𝐈𝐄𝐍𝐂𝐄𝐒    𝐑𝐨𝐬𝐥𝐢𝐧𝐂𝐓    𝐆𝐂 𝐂𝐞𝐥𝐥    𝐑𝐞𝐬𝐨𝐥𝐮𝐭𝐢𝐨𝐧 𝐓𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜𝐬    𝐓𝐂 𝐁𝐢𝐨𝐏𝐡𝐚𝐫𝐦     𝐇𝐞𝐦𝐚𝐂𝐚𝐫𝐞 𝐂𝐨𝐫𝐩𝐨𝐫𝐚𝐭𝐢𝐨𝐧, 𝐚 𝐂𝐡𝐚𝐫𝐥𝐞𝐬 𝐑𝐢𝐯𝐞𝐫 𝐂𝐨𝐦𝐩𝐚𝐧𝐲    𝐂𝐲𝐭𝐨𝐧𝐨𝐦𝐞    𝐁𝐨𝐧𝐮𝐬 𝐁𝐢𝐨𝐠𝐫𝐨𝐮𝐩   #CellTherapy #Biotechnology #HealthInnovation #MedicalResearch #GeneTherapy #Pharmaceuticals #Healthcare #LifeSciences #RegenerativeMedicine #StemCells #ClinicalTrials #CAGRGrowth #HealthTech #Biopharma #PatientCare #Immunotherapy #Biologics #DrugDevelopment #MedicalTechnology #CancerResearch #HealthOutcomes #PrecisionMedicine #Laboratory #HealthcareSolutions #HealthInvestment #BiotechIndustry #HealthEducation #DigitalHealth #PatientSafety #LaboratoryResearch #InnovationInHealthcare #HealthcareTrends #Therapeutics #CellularTherapies #HealthcareIT #MedicalDevices #ClinicalResearch #HealthEconomics #Microfluidics #DrugDiscovery #PharmaTrends #HealthcareGrowth #FutureOfHealthcare #ResearchInnovation #PatientEngagement

Check out the latest report from IMIR Market Research Pvt. Ltd. on the 𝗖𝗲𝗹𝗹 𝗖𝘂𝗹𝘁𝘂𝗿𝗲 𝗠𝗮𝗿𝗸𝗲𝘁 Outlook and Geography Forecast till 2028 Don't miss out on this opportunity to stay informed about the latest trends in the industry. Cell Culture Market Size, Share & Trends Analysis Report By Product (Consumables, Sera, Media, Reagents, Bioreactor Accessories, Instruments, Bioreactors, Cell Culture Vessels, Cell Culture Storage Equipment, Cell Culture Supporting Instruments), By End User (Research Institutes, Pharmaceutical & Biotechnology Companies, Others), By Application (Stem Cell Technology, Cancer Research, Drug Screening and Development, Tissue Engineering & Regenerative Medicine, Others), COVID-19 Impact Analysis, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2022 - 2028. 📚 𝐆𝐞𝐭 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐚𝐭 𝐝𝐢𝐬𝐜𝐨𝐮𝐧𝐭𝐞𝐝 𝐩𝐫𝐢𝐜𝐞:👇 https://lnkd.in/dyfDbVdy 📚𝐓𝐨𝐩 𝐌𝐨𝐫𝐞 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 𝐀𝐫𝐞::👇 Syros Pharmaceuticals Takeda Synchron Synthego Corporation Synthekine Takeda Pharmaceuticals (formerly Nycomed) Tectonic Therapeutic, Inc. Teva Pharmaceuticals The Janssen Pharmaceutical Companies of Johnson & Johnson Thermo Fisher Scientific Thymmune Therapeutics Torque Bio Tr1X   TransCode Therapeutics, Inc. TRIO - Translational Research in Oncology Transomic Technologies Inc. Tune Therapeutics UCB Ultragenyx Umoja Biopharma Unicycive Therapeutics Varian Vaxess Technologies Velia   Venatorx Pharmaceuticals, Inc. Ventus Therapeutics Versatope Therapeutics Vertex Pharmaceuticals Verve Therapeutics ViaCyte Vistagen VitaCyte Vyant Bio Werewolf Therapeutics Wugen WuXi Advanced Therapies WuXi Biologics XBiotech USA, Inc. Xylome   #cellculture #science #cellbiology #research #biology #molecularbiology #laboratory #biotechnology #cellculturelab #phd #phdlife #cells #womeninscience #chemistry #cell #phdstudent #laboratorylife #genetics #scientist #womeninstem #lab #pharmacology #biotech #drugdiscovery #cancerresearch #lablife #sciencelife #neurons #womendoingscience #scientistlife

Two must-attend sessions at the Oligonucleotide Therapeutics Xchange - Maryland 2024, 30 October, that you won't want to miss! Secure your free pass: https://lnkd.in/eWms8KbQ 🎯 Sponsor-led Roundtable Discussion: "Manufacturing n-of-1 Batches - Helping 1 Patient at a Time?" ⏰ 11:25 AM - 12:25 PM Join us for a sponsor-led roundtable discussion where we'll delve into the intricacies of manufacturing n-of-1 batches—a groundbreaking approach that could revolutionize personalized medicine, one patient at a time. This is a unique opportunity to engage with industry experts, exchange ideas, and explore innovative strategies in oligonucleotide manufacturing. 🎤 Poster Presentation: "Thiophosphoramidate Morpholino Oligonucleotides (TMOs): A Novel Class of PMOs Compatible With Conventional Automated Oligonucleotide Synthesis" ⏰ 3:15 PM - 3:45 PM Presented by Jeremy Little, Director of Custom Oligonucleotides at ChemGenes this session will showcase the latest advancements in TMOs—a novel class of PMOs that are set to enhance oligonucleotide synthesis. With over a decade of experience in nucleic acid drug discovery and oligonucleotide manufacturing, Jeremy brings unparalleled expertise to the table. Whether you're involved in biotech, pharma, or are just passionate about the future of oligonucleotide therapeutics, these sessions are invaluable. 💊Only available for Senior Scientists and above, from Bio and Pharma companies, with a drug pipeline. #LifeSciences #PrecisionMedicine #NucleicAcids #Pharmaceuticals #MedicalInnovation #Healthcare #Biotechnology #DrugDevelopment #MolecularBiology #ScientificResearch #GeneTherapy #OligonucleotideSynthesis #Biopharma #FutureOfMedicine #BiotechIndustry #InnovationInHealthcare #PharmaResearch #MedicinalChemistry #ClinicalResearch #ScientificRoundtable #hubXchange #Xchanges #Roundtable #FreePass #RegisterNow #ComplimentaryPass

Exciting News in Oligonucleotide Therapeutics! Professors Anastasia Khvorova and Claudio Punzo along with their UMass Chan Medical School teams, just unveiled groundbreaking research on a tetravalent conjugated #siRNA molecule. The potential for #oligonucleotide therapeutics is soaring! 💡Check out the groundbreaking study: https://lnkd.in/eM7CMZPd As these innovative molecules progress through the pharma pipeline toward IND filings and clinical studies, the need for robust characterization assays is paramount. Tried-and-true #HPLC based assays can be applied, but a lot is changing there too.  📘 To share our insights on cutting-edge separation techniques, we've crafted an information booklet. Dive into the future of oligonucleotide therapeutics LC-based analyses with us: https://lnkd.in/em-uKSHw Waters Corporation #Antisense #CRISPR sgRNA #ADAR adenosine deaminases

iPSC Market Leaders and their Business Models - https://lnkd.in/dkU6JngW Today, induced pluripotent stem cells (iPSCs) are being exploited for uses in drug discovery and development, toxicology screening, disease modelling, personalized medicine, cell-based therapeutics, and beyond. A fascinatingly diverse range of business models have been developed by market competitors to provide iPSC specific products, services, technologies, and therapies across the life science sector. iPSC market leaders by product type are the following: FUJIFILM Cellular Dynamics, Inc CDI, Ncardia, Axol Bioscience Ltd., REPROCELL, R&D Systems, Promega Corporation , Miltenyi Biotec, STEMCELL Technologies, Takara Bio Inc., Thermo Fisher Scientific, iXCells Biotechnologies, DefiniGEN, Evotec, TreeFrog Therapeutics, Catalent Pharma Solutions, Bristol Myers Squibb, Cynata Therapeutics, Century Therapeutics, Inc, and BlueRock Therapeutics. Read more at: https://lnkd.in/dkU6JngW #ipsc #stemcell #ipscells

Forecast: AI in Drug Discovery Market to Surge with 40.2% CAGR by 2028 Download Sample Report PDF: https://lnkd.in/ddwMvvFz By 2023, the global revenue from AI in drug discovery reached $0.9 billion, with forecasts indicating a rise to $4.9 billion by 2028, driven by a robust 40.2% CAGR. Enterprises operating within this industry: Ridgeline Discovery Biotage Isomorphic Labs Xaira Therapeutics Pioneering Medicines Creative Biolabs SPT Labtech Selvita BDG LifeSciences bit.bio Enable Medicine Gubra Xenon Pharmaceuticals Inc. Aurigene Oncology Limited NUVISAN The Science CRO OSE Immunotherapeutics      NovAliX Enterome Ncardia IRBM     Ardena AQEMIA Hummingbird Bioscience iLoF Light Horse Therapeutics Symeres EpiCypher, Inc. Ardigen Genomics plc Vicinitas Therapeutics Nxera Pharma Cardurion Pharmaceuticals Axol Bioscience Ltd. Optibrium Helix Biostructures Dynamic Biosensors PROTEROS biostructures GmbH Domainex #AIHealthcareTech #BiotechAI #PharmaInnovations #MedicalAIResearch #ArtificialIntelligenceInHealthcare #DrugDiscoveryTrends #BioTechInnovations #PrecisionMedicineTech #FutureOfBiotech #MedicalTechInnovation #AIForDrugDiscovery #PharmaTechTrends #BioinformaticsInMedicine #AIandBiotech #HealthcareTechnology #DrugDiscoveryRevolution #PharmaAI #TechInPharma #AIInBiotech #MedicalScienceAI